Literature DB >> 27900415

[Management of anesthesia in endovascular interventions].

T Rössel1, R Paul2, T Richter2, S Ludwig3, T Hofmockel4, A R Heller2, T Koch2.   

Abstract

Cardiovascular diseases are one of the leading causes of morbidity and mortality in Germany. In these patients, the high-risk profile necessitates an interdisciplinary and multimodal approach to treatment. Endovascular interventions and vascular surgery have become established as an important element of this strategy in the past; however, the different anatomical localizations of pathological vascular alterations make it necessary to use a wide spectrum of procedural options and methods; therefore, the requirements for management of anesthesia are variable and necessitate a differentiated approach. Endovascular procedures can be carried out with the patient under general or regional anesthesia (RA); however, in the currently available literature there is no evidence for an advantage of RA over general anesthesia regarding morbidity and mortality, although a reduction in pulmonary complications could be found for some endovascular interventions. Epidural and spinal RA procedures should be carefully considered with respect to the risk-benefit ratio and consideration of the recent guidelines on anesthesia against the background of the current study situation and the regular use of therapy with anticoagulants. The following article elucidates the specific characteristics of anesthesia management as exemplified by some selected endovascular interventions.

Entities:  

Keywords:  Anesthesia; Cerebral ischemia; Endovascular aortic repair (EVAR); Endovascular procedures; Monitoring; Risk assessment; Spinal cord ischemia; Thoracic endovascular aortic repair (TEVAR)

Mesh:

Year:  2016        PMID: 27900415     DOI: 10.1007/s00101-016-0241-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  114 in total

1.  Improvement of carotid blood flow after carotid endarterectomy--evaluation using intraoperative ultrasound flow measurement.

Authors:  H-H Eckstein; M Eichbaum; K Klemm; A Doerfler; P Ringleb; T Bruckner; J-R Allenberg
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-02       Impact factor: 7.069

2.  Incidence and risk factors for medical complications and 30-day end points after carotid artery stenting.

Authors:  Jun Wang; Yanfang Si; Sheng Li; Xiangyu Cao; Xinfeng Liu; Zhihua Du; Aili Ge; Alan Zhang; Baomin Li
Journal:  Vasc Endovascular Surg       Date:  2013-09-12       Impact factor: 1.089

3.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

4.  Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.

Authors:  Rishi Puri; Peter Libby; Steven E Nissen; Kathy Wolski; Christie M Ballantyne; Phillip J Barter; M John Chapman; Raimund Erbel; Joel S Raichlen; Kiyoko Uno; Yu Kataoka; E Murat Tuzcu; Stephen J Nicholls
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-01-20       Impact factor: 6.875

Review 5.  Endovascular methods for the treatment of intracranial cerebral aneurysms.

Authors:  Joseph J Gemmete; Augusto E Elias; Neeraj Chaudhary; Aditya S Pandey
Journal:  Neuroimaging Clin N Am       Date:  2013-05-25       Impact factor: 2.264

Review 6.  Current status of pharmacologic therapies in patient blood management.

Authors:  Lawrence Tim Goodnough; Aryeh Shander
Journal:  Anesth Analg       Date:  2012-12-07       Impact factor: 5.108

7.  The Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension. The CAPPP Group.

Authors: 
Journal:  J Hypertens       Date:  1990-11       Impact factor: 4.844

Review 8.  Lipid-lowering for peripheral arterial disease of the lower limb.

Authors:  P P Aung; H G Maxwell; R G Jepson; J F Price; G C Leng
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Authors: 
Journal:  Can J Cardiol       Date:  1996-02       Impact factor: 5.223

Review 10.  Systematic Review and Meta-analysis of Long-term survival After Elective Infrarenal Abdominal Aortic Aneurysm Repair 1969-2011: 5 Year Survival Remains Poor Despite Advances in Medical Care and Treatment Strategies.

Authors:  S S Bahia; P J E Holt; D Jackson; B O Patterson; R J Hinchliffe; M M Thompson; A Karthikesalingam
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-06-23       Impact factor: 7.069

View more
  1 in total

1.  General anesthesia versus monitored anesthesia care during endovascular therapy for vertebrobasilar stroke.

Authors:  Guangjun Hu; Zhen Shi; Bixi Li; Weidong Shao; Bo Xu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.